Lokesh Saini is an expert in Pediatrics at All India Institute of Medical Sciences Jodhpur (India). As of October 2026, ScienceLeadR ranks Lokesh Saini in the top 1% of experts in India for Congenital Abnormalities. Lokesh Saini has authored 387 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 1,204 (community average: 125). How the SLR is computed.

LeadR Profile

1 204 ScienceLeadR Reputation 1204
Network Map

Pediatrics

Subspecialties: Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026

Source: PubMed

All India Institute of Medical Sciences

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 387

Citations

Citations: 1 525 1st author: 45 Last author: 136 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Early-Onset Epilepsy with Developmental Delay - A Novel C.1640A>C Mutation in the SETD1A Gene with Sensorineural Hearing Loss.
PMID 42700128 — genes, epilepsy, hearing, hearing loss, sensorineural, hearing loss, neurology, mutation, psychiatry
Neurol India20260
Referral to an Apex Tertiary Center in Pediatric Epilepsy: A Prospective Cost-of-Illness Study.
PMID 42639310 — epilepsy, cost of illness, child
Indian J Community Med20260
Persistence and Dissipation Pattern of Azoxystrobin and Difenoconazole in Turmeric (Curcuma longa L.).
PMID 42626558 — soil
ACS Omega20260
Building a pediatric spasticity surgery program in a low-awareness setting: capacity creation, multidisciplinary integration, and early outcomes.
PMID 42622914 — absenteeism, contracture, orthopedics, therapeutics, nervous system diseases, surgeons, paraparesis
Childs Nerv Syst20260
Effect of Cannabinoids use on Symptoms of Restless Leg Syndrome among Adults: A Scoping Review.
PMID 42617004 — signs and symptoms, cannabinoids, restless legs syndrome
Ann Indian Acad Neurol20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 2

By status:

Completed 1
Recruiting 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
NCT07369011 — safety, sleep apnea, obstructive, sleep, apnea, obesity, sleep apnea syndromes, therapeutics, overweight
Phase 3Recruiting2026

LeadR Networks

Main global connection map